Quarterly Transactions Made in Supernus Pharmaceuticals, Inc. (SUPN)
This table provides information about the institutional ownership of Supernus Pharmaceuticals, Inc. (SUPN). The information is specifically focused on institutions that hold shares of SUPERNUS PHARMACEUTICALS, INC..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 2,868,798 | 2,378,760 | 5,247,558 | 3,648,798 | 659,016 | 4,307,814 | 939,744 | |
| Q4 2021 | 1,908,990 | 2,327,653 | 4,236,643 | 2,165,148 | 928,877 | 3,094,025 | 1,142,618 | |
| Q1 2022 | 1,828,777 | 1,252,319 | 3,081,096 | 3,553,140 | 1,524,183 | 5,077,323 | -1,996,227 | |
| Q2 2022 | 6,651,327 | 1,374,566 | 8,025,893 | 5,640,196 | 355,776 | 5,995,972 | 2,029,921 | |
| Q3 2022 | 2,657,589 | 1,247,455 | 3,905,044 | 1,588,772 | 8,355 | 1,597,127 | 2,307,917 | |
| Q4 2022 | 2,467,817 | 2,078,736 | 4,546,553 | 2,408,068 | 0 | 2,408,068 | 2,138,485 | |
| Q1 2023 | 2,718,844 | 973,444 | 3,692,288 | 2,885,357 | 721 | 2,886,078 | 806,210 | |
| Q2 2023 | 3,790,593 | 1,008,309 | 4,798,902 | 1,846,270 | 428,573 | 2,274,843 | 2,524,059 | |
| Q3 2023 | 2,108,631 | 1,456,283 | 3,564,914 | 2,185,106 | 428,573 | 2,613,679 | 951,235 | |
| Q4 2023 | 2,720,580 | 1,356,283 | 4,076,863 | 2,417,982 | 0 | 2,417,982 | 1,658,881 | |
| Q1 2024 | 1,276,515 | 2,080,777 | 3,357,292 | 3,012,633 | 0 | 3,012,633 | 344,659 | |
| Q2 2024 | 6,025,341 | 976,313 | 7,001,654 | 3,054,760 | 0 | 3,054,760 | 3,946,894 | |
| Q3 2024 | 2,798,630 | 823,476 | 3,622,106 | 1,353,457 | 33,770 | 1,387,227 | 2,234,879 | |